Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05821530 · ClinicalTrials.gov registry record · NA

HFIT Versus TENS Study for Chronic Low Back and Knee Pain

A NA study of Chronic Pain and Knee Pain Chronic, sponsored by Hinge Health.

Active
Registry status
NA
Development phase
325
Enrollment target
1
Study location

NCT05821530 is a NA study of Chronic Pain and Knee Pain Chronic that is active but no longer recruiting, run by Hinge Health. The registered enrollment target is 325 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05821530, a NA study of Chronic Pain and Knee Pain Chronic, is active but no longer recruiting, sponsored by Hinge Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
325 participants
Enrollment target
1
Study location

Study Summary

A high-frequency impulse therapy (HFIT) device (Enso, San Francisco, CA) is a portable device for the treatment of musculoskeletal pain. This three-arm randomized controlled trial study compares a HFIT group to a standard transcutaneous electrical nerve stimulator (TENS) group and a control group.

Interventions

  • OTHER Control
  • DEVICE TENS
  • DEVICE HFIT

Study Locations (1)

California

  • Hinge Health, Inc - San Francisco

Trial Details

FieldValue
Enrollment Target 325 participants
Start Date 2023-04-24
Est. Completion 2023-06-30
Phase NA

Sponsor

Hinge Health

4 total trials

What the Registry Record Tells You About NCT05821530

The ClinicalTrials.gov registry entry for NCT05821530 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (58% lower). The listed sponsor is Hinge Health, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT05821530 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05821530 about?

NCT05821530 is a clinical study titled "HFIT Versus TENS Study for Chronic Low Back and Knee Pain". A high-frequency impulse therapy (HFIT) device (Enso, San Francisco, CA) is a portable device for the treatment of musculoskeletal pain. This three-arm randomized controlled trial study compares a HFIT group to a standard transcutaneous electrical nerve stimulator (TENS) group and a control group.

What is the current status of trial NCT05821530?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 325 participants. The study started on 2023-04-24. Estimated completion is 2023-06-30.

What conditions does trial NCT05821530 study?

This clinical trial studies the following conditions: Chronic Pain, Knee Pain Chronic, Back Pain, Low.

What interventions are being tested in trial NCT05821530?

The interventions under investigation include: Control (OTHER), TENS (DEVICE), HFIT (DEVICE).

Who is sponsoring clinical trial NCT05821530?

This trial is sponsored by Hinge Health, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05821530 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.